ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1846

Mitochondrial Dysfunction Induces An Inflammatory, Tissue-Degrading, and Angiogenic Response In Normal Human Synoviocytes

M. Noa Valcárcel-Ares1, Romina R. Riveiro-Naveira1, Jesus Loureiro1, Carlos Vaamonde-García1, Laura Hermida-Carballo1, Francisco J. Blanco2 and Maria J. López-Armada1, 1Aging and Inflammation Research Lab, INIBIC-CHU A Coruña, A Coruña, Spain, 2Osteoarticular and Aging Res. Lab. CIBER-BBN. INIBIC- University of A Coruña, A Coruña, Spain

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Angiogenesis, Inflammation, inflammatory arthritis, joint destruction and mitochondria

  • Tweet
  • Email
  • Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Tissues affected with inflammatory arthritis (IA) are subjected to great levels of oxidative stress. Synoviocytes from IA patients present a higher rate of mitochondrial DNA mutagenesis and mitochondrial dysfunction than those from healthy donors. In this work, we studied the role of mitochondrial dysfunction in the inflammatory, tissue-degrading and angiogenic response in human synoviocytes, as those are pivotal processes occurring in IA. 

Methods: Mitochondrial dysfunction was induced in normal human synoviocytes with the ATPase inhibitor oligomycin (OLI). Antimycin (AA) and paraquat (PQ) were also used. Mitochondrial polarization was evaluated by TMRM staining; and cytosolic and mitochondrial superoxide production by DHE and mitoSOX staining, respectively. Cyclooxygenase-2 (COX-2), interleukin (IL)-8, metalloproteinase (MMP)-1, MMP-3 and vascular endothelial growth factor (VEGF) mRNA expression were evaluated by RT-PCR.  COX-2 protein expression was tested by flow cytometry whereas prostaglandin E2 (PGE2), IL-8, and MMP-1/3 levels were assayed by ELISA. In order to establish the role of ROS production, the general and mitochondria-targeted ROS scavengers N-acetylcysteine (NAC) and mitoTEMPO, respectively, were employed. The involvement of NF-kappaB was evaluated by using the inhibitor BAY. Also p65 translocation to the nucleus and NF-kappaB binding activity were assayed by immunofluorescence and EMSA, respectively. The protecting effect of the natural antioxidant resveratrol (RSV) was tested.

Results: OLI induced mitochondrial depolarization and mitochondrial and cytosolic ROS production. OLI-treated synoviocytes showed an increased inflammatory response (as determined by COX-2, PGE2, and IL-8 expression) as well as a tissue-degrading phenotype confirmed by an increase in MMP-1/3 expression and an angiogenic potential (as evaluated by VEGF mRNA expression and tube formation assay). Besides, in the presence of IL-1β (one of the key pro-inflammatory mediators in IA affected tissues) synoviocytes with mitochondrial dysfunction exhibit a synergic effect regarding the expression of COX-2, PGE2, and IL-8, as well as MMP-1/3 as compared with healthy synoviocytes. When the role of ROS was investigated, we found that NAC and mitoTEMPO significantly reversed the inflammatory response. Involvement of NF-kappaB was confirmed when the inflammatory response was reduced after incubation with BAY; besides, p65 translocation to the nucleus and NF-kappaB binding activity were found in synoviocytes treated with OLI and IL-1β + OLI. AA and PQ showed a similar effect on the inflammatory response. Finally, RSV clearly prevented inflammation, MMP production and the angiogenic response. 

Conclusion: The present study confirms the implication of mitochondria in the proinflammatory, tissue-degrading and angiogenic response in human synoviocytes. Also mitochondrial dysfunction sensitizes these cells amplifying the effect of IL-1β. The responses of synoviocytes with dysfunctional mitochondria are mediated at least in part by mitochondrial ROS production and NF-kappaB activation. RSV has proven to be effective in controlling the deleterious effect of mitochondrial dysfunction.


Disclosure:

M. N. Valcárcel-Ares,
None;

R. R. Riveiro-Naveira,
None;

J. Loureiro,
None;

C. Vaamonde-García,
None;

L. Hermida-Carballo,
None;

F. J. Blanco,
None;

M. J. López-Armada,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mitochondrial-dysfunction-induces-an-inflammatory-tissue-degrading-and-angiogenic-response-in-normal-human-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology